Estimating the cost-effectiveness of screening for hepatitis C virus infection in Japan / 日本におけるC型肝炎ウイルス検診の費用対効果の推定

Description

京都大学 / 新制・課程博士 / 博士(社会健康医学) / 甲第23120号 / 社医博第116号 / 新制||社医||11(附属図書館) / 京都大学大学院医学研究科社会健康医学系専攻 / (主査)教授 今中 雄一, 教授 中山 健夫, 教授 佐藤 俊哉 / 学位規則第4条第1項該当 / Doctor of Public Health / Kyoto University / DFAM

Links & Downloads

1. http://hdl.handle.net/2433/263581
2. 14301甲第23120号
3. 10.14989/doctor.k23120
4. 14301

Tags

cost-effectiveness

direct-acting antiviral

hepatitis C virus

Japan

screening

493

Additional Fields

Identifer	oai:union.ndltd.org:kyoto-u.ac.jp/oai:repository.kulib.kyoto-u.ac.jp:2433/263581
Date	23 March 2021
Creators	Nagai, Kota
Contributors	長井, 耕太, ナガイ, コウタ
Publisher	Kyoto University, 京都大学
Source Sets	Kyoto University
Language	English
Detected Language	English
Type	doctoral thesis, Thesis or Dissertation
Rights	This is the peer reviewed version of the following article: Nagai K, Ide K, Kawasaki Y, Tanaka-Mizuno S, Seto K, Iwane S, Eguchi Y, Kawakami K. Estimating the cost‐effectiveness of screening for hepatitis C virus infection in Japan. Hepatol Res. 2020, which has been published in final form at https://onlinelibrary.wiley.com/doi/full/10.1111/hepr.13478. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Relation	https://doi.org/10.1111/hepr.13478